Skip to content
BY 4.0 license Open Access Published by De Gruyter May 11, 2021

Is there any relationship between C-reactive protein/albumin ratio and clinical severity of childhood community-acquired pneumonia

C-Reaktif Protein/Albümin Oranı ile Çocukluk Çağı Toplum Kökenli Pnömoninin Klinik Şiddeti Arasında İlişki Var mı?
  • Hayrunnisa Bekis Bozkurt ORCID logo EMAIL logo

Abstract

Objectives

To investigate the relationship between the ratios of C-reactive protein (CRP)/albumin, neutrophil/lymphocyte (NLR), monocyte/lymphocyte (MLR), mean platelet volume (MPV)/platelet and erythrocyte sedimentation rate (ESR)/albumin in pediatric patients diagnosed with community-acquired pneumonia based on the severity of the disease.

Methods

This retrospective cross-sectional study included 52 patients with mild pneumonia, 30 with severe pneumonia, and 46 healthy controls. Whole blood parameters, CRP, ESR, and albumin values and ratios were recorded at the time of admission. The multivariate regression analysis, Pearson’s correlation and ROC curve analyses were performed.

Results

The CRP/albumin, ESR/albumin, NLR and CRP values were significantly higher in the severe pneumonia group compared to both the other pneumonia group and the control group (p<0.005). According to the regression and correlation analyses, these values were positively correlated (p<0.001). For CRP/Albumin ratio, ESR/albumin ratio calculated OR were 2.103 (CI: 1.675–2.639); 1.907 (CI: 1.552–2.344); respectively.

Conclusions

The data presented can be a guide in the follow-up and treatment of this patient group.

Özet

Amaç

Toplum kökenli pnömoni tanısı almış çocuklarda hastalığın şiddeti ile C-reaktif protein (CRP)/albumin, nötrofil/lenfosit (NLR), monosit/lenfosit (MLR), mean platelet volum (MPV)/platelet and eritrosit sedimentasyon hızı(ESR)/albumin oranları arasındaki ilişkinin değerlendirilmesi.

Metot

Retrospektif ve kesitsel olarak tasarlanan bu çalışmaya 52 hafif pnömoni olgusu, 30 ağır pnömoni olgusu, 46 sağlıklı control dahil edildi. Tam kan sayımı, CRP, ESR, ve albumin değerleri ve oanları başvuru anında kaydedildi. Multivaryant regresyon, Pearson korelasyon analizi ve ROC eğrisi analizleri çalışıldı.

Bulgular

CRP/albumin, ESR/albumin, NLR ve CRP değerleri ağır pnömoni grubunda hafif pnömoni ve sağlıklı kontrole göre anlamlı şekilde yüksek bulundu (p<0.005). Bu değerlerde benzer şekilde poziif korelasyon tespit edildi (p<0.001). CRP/albumin oranı ve ESR/albumin oranı için Odds oranı(OR) sırası ile 2.103 (CI: 1.675–2.639); 1.907 (CI: 1.552–2.344) olarak hesaplandı.

Sonuç

Sunulan veriler bu hastaların takip ve tedavisinde yol gösterici olabilir.

Introduction

Community-acquired pneumonia (CAP) is an important disease, leading to mortality in children under the age of five years, especially in developing countries [1]. According to the data of the World Health Organization, approximately one million children die every year due to CAP and lower respiratory tract infection [2]. The diagnosis of CAP is made based on clinical, radiological and laboratory findings. International guidelines have developed various diagnostic criteria that are mainly based on clinical signs and symptoms. Lung radiology or biochemical markers do not have 100% sensitivity or specificity [3]. In addition to combating risk factors, such as low birth weight, malnutrition, poor hygiene, and insufficient and/or unsafe food, early and timely interventions to the disease contribute to reducing mortality among children. Although the incidence of CAP has decreased due to conjugated pneumococcal vaccines developed recently, viral and atypical factors have started to replace pneumococcal strains [3], [4]. Therefore, the need for laboratory parameters to be combined with clinical findings in diagnosis and prognosis has increased.

In recent studies, the role of many biochemical markers in diagnosis and prognosis in childhood pneumonia has been investigated. Among the most frequently researched are C-reactive protein (CRP), neutrophil/lymphocyte ratio (NLR), white blood cell (WBC) count, mean platelet volume (MPV), platelet number, procalcitonin, and interleukin-1 [5], [6]. CRP is a positive acute-phase reactant elevated in many infections, autoimmune diseases. Although erythrocyte sedimentation rate (ESR) increases slower than CRP, it is a positive acute-phase reactant, especially observed in rheumatological diseases, malignancies, and infections. Albumin is a negative acute-phase reactant inversely correlated with the severity of inflammation in various diseases [7]. In studies conducted, the ratio of CRP/albumin has been found to be a more sensitive marker in many diseases from malignancies to cardiovascular disorders and from infections to autoimmune diseases [7], [8]. Although we could not find information about the ESR/Albumin ratio in the literature, it is known that ESR and albumin levels can be important guides in inflammation [9]. The ESR/albumin ratio may also be a sensitive marker in this regard [9].

To our knowledge, this is the first study to investigate the relationship of CRP/albumin and ESR/albumin with childhood CAP. We aimed to investigate the relationship between the diagnosis and clinical severity of CAP and the CRP/albumin, ESR/albumin, NLR, and platelet/MPV values.

Materials and methods

This retrospective cross-sectional study included 52 patients diagnosed with mild pneumonia and 30 with severe pneumonia according to the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America (PIDS/IDSA) classification [10], and 46 healthy children as the control group. The inclusion criteria for the study were presenting at our healthy child polyclinic for follow-up regarding child growth and development or being brought in for routine health exams, being in the similar age range, having no chronic diseases, having neither malnutrition nor obesity, being born full-term, having no acute infection, having no anaemia or polycythaemia, and having no kidney, lung, or liver diseases. In the diagnosis of CAP from three to 72 months of age, radiographic findings (lobar infiltration, round infiltration, consolidation, and interstitial involvement) and the presence of a higher respiratory rate than normal for age were taken into consideration. In addition to radiographic involvement and follow-up, the presence of any of sign of dyspnea, fever, retraction, and pathological auscultation was noted. The PIDS/IDSA classification (need for oxygenation, PaO2/Fio2<250, two or more of the symptoms of multilobar involvement, dyspnea, retraction, apnea, or fever) was used in the diagnosis of severe pneumonia [10]. Patients with immune deficiency, malnutrition, chronic kidney disease, cystic fibrosis, diabetes mellitus requiring chronic drug use, and connective tissue disease (systemic lupus erythematosus, familial Mediterranean fever, juvenile idiopathic arthritis, etc.) and those with defined syndromes or syndromic appearance were excluded from the study. A further 42 patients were excluded from the study due to incomplete records. The patients diagnosed with pneumonia were followed up and treated by the same pediatrician. The patients’ age, gender, physical examination findings at first admission, NLR, WBC/lymphocyte, platelet/MPV, CRP/MPV, CRP/albumin, ESR/albumin, and monocyte/lymphocyte (MLR) were recorded from the electronic files. Samples of patients were taken at the time of diagnosis, first day of hospitalization. The relationship between these ratios and the severity of the disease was investigated. In the study, the complete blood count analysis was performed using a flow cytometric method with an ABX-Pentra DX 120 (Horiba LTD, Japan) device, and serum CRP and albumin analysis were performed using the photometric method with a Cobas C501 (Roche Diagnostic, Germany) device and ESR analysis was performed using the Modified Westergren method with SDM-100 (Berkhun, Turkey). For haemogram, purple capped K2EDTA tubes; for biochemistry, tubes with gel; for sedimentation, tubes with sodium citrate were used. All of them were standardized. Prior to the study, the local ethics committee approval was received (2019/80576354-050-99/113), and the study was conducted in accordance with the principles of the Helsinki Declaration.

The Statistical Package for Social Sciences (SPSS) v. 22 for Windows (IBM SPSS Inc., Chicago, USA) was used for the analysis of the data. The normal distribution of the data was evaluated using the Kolmogorov-Smirnov test. The categorical variables were presented as numbers and percentages. The numerical values between the pneumonia and severe pneumonia groups were compared using Student’s t-test and Mann-Whitney U test, while one-way ANOVA and the Kruskal-Wallis test were used to compare the data between the three groups. The chi-square and Fisher’s exact tests were conducted to compare the categorical data. The diagnostic discrimination of independent predictors for severity was examined using multivariate regression analysis and area under the curve (AUC) in receiver operating characteristic (ROC) curve analyses. The Pearson correlation test was used to analyze the correlations between CRP/albumin and NLR, NLR and CRP, CRP/albumin and CRP, and NLR and ESR/albumin, and then the R2 linear value was calculated. In statistical analysis, a p value of <0.05 was considered statistically significant at the 95% confidence interval (CI) and 5% margin of error.

Results

A total of 128 children, (52 with pneumonia, 30 with severe pneumonia, and 46 healthy controls) were included in the study. There were no significant differences in age and gender between the patient and control groups (p=0.693 and p=0.203, respectively). As expected, the complication rate and length of hospital stay were significantly higher in patients with severe pneumonia (p=0.002 and p=0.001, respectively). The CRP, ESR, albumin, neutrophil and lymphocyte values also significantly differed both between the pneumonia groups and the control group, as well as between the severe pneumonia and pneumonia groups (p=0.019, 0.03, 0.001, 0.004, and 0.009, respectively). Table 1 present the comparison of the demographic and laboratory parameters of the groups. The ratios of NLR, CRP/albumin and ESR/albumin were significantly higher in the severe pneumonia group (p=0.045, 0.016, and 0.003, respectively) (Table 2). In the ROC curve and regression analyses, AUC was calculated as 0.830 (CI: 0.754–0.906) for CRP/albumin, 0.787 (CI: 0.701–0.873) for ESR/albumin, and 0.785 (CI: 0.698–0.871) for CRP. The CRP/albumin ratio presented as a valuable marker with 86.7% sensitivity and 70.4% specificity (Figure 1). When analyzed by linear regression and Pearson’s correlation analysis, the CRP/albumin ratio was strongly correlated with CRP (R2=0.967, p<0.001) and weak positively correlated with NLR (R2=0.125, p<0.001). A weak positive relationship was also detected between NLR and CRP and between ESR and NLR (R2=0.137, p=0.001 and R2=0.054, p=0.008, respectively) (Figure 2). When we separated patients into two groups according to hospitalization length as 6 days or above and 5 days or below, we found that a significant difference (p=0.016), CRP/Albumin ratio is significant high in the group of hospitalization length was 6 days or above (CRP/Albumin ratio was 0.95 ± 1.22 and 0.47 ± 0.53; respectively). For CRP/Albumin ratio, ESR/albumin ratio and NLR, calculated OR were 2.103 (CI: 1.675–2.639); 1.907 (CI: 1.552–2.344); 1.378 (CI: 0.668–2.845) respectively.

Table 1:

Evaluation of some demographic and laboratory parameters between groups.

Pneumonia Severe pneumonia Control p1-Value p2-Value
Age, years 3.404 ± 2.178 3.933 ± 2.258 4.228 ± 1.569 0.123 0.693
Gender, n (Male/Female) 29/23 12/18 19/27 0.247 0.203
Complication, na (Right heart failure, pneumothorax, pleural effusion), % 3/52 (5.7) 10/30 (33.3) 0.002
Hospitalization, day (mean ± SD) 4.92 ± 0.737 7.10 ± 1.348 0.001
WBC, x103/mm3 10.28 ± 4.32 11.51 ± 6.44 8.84 ± 2.60 0.036 b 0.306
Neutrophil, x103/µL 4.40 ± 3.32 7.11 ± 4.83 4.34 ± 2.56 0.001 b 0.004
Lymphocyte, x103/µL 4.67 ± 2.34 3.39 ± 1.56 3.60 ± 1.41 0.003 b 0.009
Monocyte, x103/µL 0.89 ± 0.46 1.16 ± 1.3 1.06 ± 1.4 0.516 0.172
Hb, g/dL (mean ± SD) 12.08 ± 1.52 12.36 ± 1.75 12.91 ± 1.51 0.035 0.457
Platelet, x103/µL 395.77 ± 129.57 348.73 ± 117.54 337.85 ± 87.39 0.113b 0.106
MPV, fL 7.92 ± 0.78 8 ± 0.67 7.87 ± 0.63 0.732 0.633
CRP, mg/dL 1.96 ± 2.21 3.80 ± 4.74 0.13 ± 0.14 <0.001 b 0.019
ESR, mm/h 26.44 ± 22.6 38.63 ± 26.59 7.85 ± 4.1 <0.001 b 0.03
Albumin, g/dL 4.28 ± 0.42 3.93 ± 0.37 4.17 ± 0.34 0.001 0.001
  1. Mean ± SD are given. p1-Value, between all groups, One way Anova; p2-Value, between pneumonia and severe pneumonia, Oneway Anova-Bonferonni test; aChi-square test. bKruskall Wallis test. Bold and italic p values are p<0.005.

Table 2:

Comparison of some proportional values between groups.

Pneumonia Severe pneumonia Control p1-Value p2-Value
NLR 1.47 ± 2.52 2.56 ± 1.90 1.5 ± 1.28 0.041 0.045
MLR 0.24 ± 0.21 0.36 ± 0.33 0.37 ± 0.6 0.233 0.042
WBC/Lymphocyte 2.79 ± 2.75 3.91 ± 2.15 2.78 ± 1.37 0.055 0.061
Plt/MPV 50.51 ± 17.22 44.54 ± 17.88 43.5 ± 13.05 0.074a 0.140
CRP/MPV 0.25 ± 0.28 0.48 ± 0.63 0.017 ± 0.018 0.001 0.055
CRP/Albumin 0.46 ± 0.53 1.05 ± 1.26 0.032 ± 0.034 <0.001 0.016
ESR/Albumin 6.15 ± 5.69 9.24 ± 7.25 1.86 ± 0.91 <0.001 0.003
  1. Mean ± SD are given. p1-Value, between all groups, One way Anova; p2-Value, between pneumonia and severe pneumonia, Student-t test; aKruskall Wallis test. Bold and italic p values are p<0.005.

Figure 1: 
ROC curve analysis among CRP, CRP/Albumin, NLR, ESR/Albumin and MLR.
Figure 1:

ROC curve analysis among CRP, CRP/Albumin, NLR, ESR/Albumin and MLR.

Figure 2: 
Significant correlation between CRP/Albumin and NLR; NLR and CRP; CRP/Albumin and CRP; NLR and ESR/Albumin; p<0.001.
Figure 2:

Significant correlation between CRP/Albumin and NLR; NLR and CRP; CRP/Albumin and CRP; NLR and ESR/Albumin; p<0.001.

Discussion

Pediatric CAP is one of the leading causes of child deaths that can be prevented by timely diagnosis and treatment. The guidelines developed for diagnosis and clinical scoring are mainly based on clinical signs and symptoms. Biomarker studies with high sensitivity and specificity gain importance due to the low rate of the production of pathogen in blood culture and the need for at least seven to 10 days for the results. In previous studies, many markers, including WBC, NLR, CRP, procalcitonin, and IL-6 have been investigated [3], [5], [10]. In a study involving 394 suspected children with pneumonia, CRP and WBC were positively correlated with positive chest radiography and proven pneumonia [5]. In another study, with 92 children consisting of 46 patients of bacterial pneumonia, they investigated the diagnostic accuracy of procalcitonin as compared with C-reactive protein (CRP) and found the area under receiver characteristic curves for procalcitonin and CRP were 0.89 (95% CI=0.83–0.96) and 0.79 (95% CI=0.70–0.88), respectively [11]. According to guidelines based on many studies, for a complete blood cell count has weak recommendation; low-quality evidence but for acute phase reactant (ESR, CRP, procalcitonin) have strong recommendation; high-quality evidence [3], [10]. However, to the best of our knowledge, this is the first study to examine the relationship of clinical severity of pneumonia with CRP/albumin and ESR/albumin and in hospitalized children diagnosed with CAP. The CRP, ESR, neutrophil and lymphocyte values were found to be significantly higher and albumin was significantly lower in the severe pneumonia group. Although the ratios of NLR, CRP/albumin and ESR/albumin were higher in the severe pneumonia group, there was no significant difference in the platelet, MPV, platelet/MPV and CRP/MPV values.

CRP is an important marker that induces cytokine release within eight to 12 h after acute inflammation and is either not affected or only minimally affected by age and sex, and thus it is often used in the diagnosis and follow-up of acute inflammation [12]. On the other hand, ESR seems to be important in the follow-up of chronic diseases, and it has been reported that it can be used to predict the duration of hospitalization in children with pneumonia [12], [13]. In a study conducted by Lee et al. with hospitalized children diagnosed with CAP, the AUC values were reported as 0.77 (95% CI=0.59–0.95) for CRP and 0.73 (95% CI=0.54–0.92) for ESR [14]. In the literature, CRP is presented as a more sensitive and specific marker for CAP but it is recommended to be used together with ESR because of the false positivity can be seen, such as obesity and trauma [15]. These results were similar to our study (Table 1, Table 3).

Table 3:

Comparison of the ratios (CRP/Albumin, CRP, NLR, ESR/Albumin, MLR) according to ROC curve.

Sensitivity Spesifity Cut-off value AUC p-Value 95% CI
(%) (%) Lower bound Upper bound
CRP 83.3 67.3 0.742 0.785 <0.001 0.698 0.871
CRP/Albumin 86.7 70.4 0.215 0.830 <0.001 0.754 0.906
NLR 76.7 62.2 1.12 0.722 0.001 0.619 0.825
ESR/Albumin 80 68.4 3.85 0.787 <0.001 0.701 0.873
MLR 73.4 54.1 0.19 0.653 0.012 0.542 0.764

NLR is known to increase in inflammation and is induced especially by IL-6 and TNF released by T cells [16]. NLR, which is considered to be a predictor in many inflammatory events, was found to be higher in children diagnosed with Familial Mediterranean Fever during the attack and correlated with the clinical severity score in children with cystic fibrosis [17], [18]. In a study by Kartal et al. in children with CAP, a positive correlation was found between NLR and CRP, and it was emphasized that NLR could be an important marker, especially for hospitalized patients with CAP [19]. In another study, Bekdas et al. stated that NLR could be used to predict complications in children with pneumonia. In the same study, it was shown that the CRP/MPV ratio was a more sensitive and specific marker than NLR for complicated pneumonia cases. In the ROC analysis, the authors found AUC as 0.85 (95% CI=0.70–0.99) for CRP/MPV and 0.77.5 (95% CI=0.62–0.92) for NLR [20]. In our study, the CRP/MPV ratio did not statistically significantly differ between the groups (Table 2). The platelet count, MPV, and the ratios of these values have been investigated in relation to many inflammations, but considering that these ratios can also be affected by body mass index, age, gender, and drugs used, their role in routine diagnosis remains limited [21], [22], [23].

Better understanding the value of albumin in predicting the chronic process and prognosis of the disease and the role of CRP in the acute period and follow-up of inflammation leads to idea that the CRP/albumin ratio may be a more sensitive biomarker. As the severity of pneumonia increases in immune competent patients, cytokine storm (especially IL-1,6 and TNF alpha) appears more strongly, secondary CRP production increase in hepatocytes is inevitable [24]. In addition to the negative effect of cytokine increase on albumin production is known, increase in metabolic rate in severe pneumonia, acute relative malnutrition, increase in vascular permeability with the effect of inflammation may cause low albumin [25]. CRP/Albumin ratio presents as a marker in the follow-up and prognosis of critical elderly patient [26]. In studies conducted to date, it has been shown that in many infections, malignancies and vasculitis, this ratio is correlated with the severity of inflammation and prognosis [27], [28], [29], [30]. In a three-year prospective study in children with cystic fibrosis, the high CRP/albumin ratio was reported to be associated with <70% of forced expiratory volume in 1 s and was suggested as an important parameter in predicting lung function [31]. Other studies have also demonstrated the prognostic significance of albumin and CRP values in CAP diagnosis [32]. In a study conducted with 483 adults, it was emphasized that the CRP/albumin ratio was associated with the severity of pneumonia and could be an independent and easily accessible prognostic marker for this disease [33]. To our knowledge, our study is the first to evaluate the relationship between CRP/albumin and the severity of childhood CAP.

ESR, which is another marker that is elevated in the inflammatory state, is affected by plasma immunoglobulins and fibrinogens [15]. Low albumin may lead to a false low measurement of ESR [15], [34]. This suggests that elevated ESR may be much more valuable than low albumin levels. Therefore, the ESR/albumin ratio can be used as a new prognostic marker in inflammatory diseases. However, there are not sufficient data about this ratio in the literature. In our study, we found the ratio of CRP/albumin to be more sensitive, but the ESR/albumin ratio was also valuable in terms of showing clinical severity (Figure 1, Figure 2).

The limitations of our study concern its retrospective nature and small sample size. Another limitation is that the parameters were not analyzed during the follow-up of patients. Prospective studies with larger patient populations are required.

In conclusion, CRP/albumin and ESR/albumin ratios may be used as markers for the severity of the childhood CAP. The data presented in this paper can be a guide for the follow-up and early treatment of this patient group.


Corresponding author: Hayrunnisa Bekis Bozkurt, MD, Department of Pediatrics, Faculty of Medicine, Medeniyet University, İstanbul, Turkey, Phone: +90 5428465003, E-mail:

Acknowledgement

Special thanks: Thanks to Dr. Fatih Kara for his contribution. Assistant Professor, Kafkas University, Faculty of Medicine, Department of Biochemistry.

  1. Research funding: None.

  2. Author contributions: The author has accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interest: None.

  4. Ethical approval: The local ethics committee approval was received (80576354-050-99/113, 03/04/2019).

References

1. Qin, Q, Shen, KL. Community-acquired pneumonia and its complications. Indian J Pediatr 2015;82:745–51. https://doi.org/10.1007/s12098-015-1785-4.Search in Google Scholar PubMed

2. Le Roux, DM, Zar, HJ. Community-acquired pneumonia in children – a changing spectrum of disease. Pediatr Radiol 2017;47:1392–8. https://doi.org/10.1007/s00247-017-3827-8.Search in Google Scholar PubMed PubMed Central

3. Messinger, AI, Kupfer, O, Hurst, A, Parker, S. Management of pediatric community-acquired bacterial pneumonia. Pediatr Rev 2017;38:394–409. https://doi.org/10.1542/pir.2016-0183.Search in Google Scholar PubMed

4. Esposito, S, Principi, N. Impacts of the 13-valent pneumococcal conjugate vaccine in children. J Immunol Res 2015;2015:591580. https://doi.org/10.1155/2015/591580.Search in Google Scholar PubMed PubMed Central

5. Berg, AS, Inchley, CS, Fjaerli, HO, Leegaard, TM, Lindbaek, M, Nakstad, B. Clinical features and inflammatory markers in pediatric pneumonia: a prospective study. Eur J Pediatr 2017;176:629–38. https://doi.org/10.1007/s00431-017-2887-y.Search in Google Scholar PubMed

6. Florin, TA, Ambroggio, L. Biomarkers for community-acquired pneumonia in the emergency department. Curr Infect Dis Rep 2014;16:451. https://doi.org/10.1007/s11908-014-0451-8.Search in Google Scholar PubMed

7. Kinoshita, A, Onoda, H, Imai, N, Iwaku, A, Oishi, M, Tanaka, K, et al.. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol 2015;22:803–10. https://doi.org/10.1245/s10434-014-4048-0.Search in Google Scholar PubMed

8. Ranzani, OT, Zampieri, FG, Forte, DN, Azevedo, LC, Park, M. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PloS One 2013;8:e59321. https://doi.org/10.1371/journal.pone.0059321.Search in Google Scholar PubMed PubMed Central

9. van Atteveld, VA, Van Ancum, JM, Reijnierse, EM, Trappenburg, MC, Meskers, CGM, Maier, AB. Erythrocyte sedimentation rate and albumin as markers of inflammation are associated with measures of sarcopenia: a cross-sectional study. BMC Geriatr 2019;19:233. https://doi.org/10.1186/s12877-019-1253-5.Search in Google Scholar PubMed PubMed Central

10. Bradley, JS, Byington, CL, Shah, SS, Alverson, B, Carter, ER, Harrison, C, et al.. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011;53:e25–76. https://doi.org/10.1093/cid/cir531.Search in Google Scholar PubMed PubMed Central

11. Khan, DA, Rahman, A, Khan, FA. Is procalcitonin better than C-reactive protein for early diagnosis of bacterial pneumonia in children? J Clin Lab Anal 2010;24:1–5. https://doi.org/10.1002/jcla.20333.Search in Google Scholar PubMed PubMed Central

12. Litao, MK, Kamat, D. Erythrocyte sedimentation rate and C-reactive protein: how best to use them in clinical practice. Pediatr Ann 2014;43:417–20. https://doi.org/10.3928/00904481-20140924-10.Search in Google Scholar PubMed

13. Sakellaropoulou, A, Hatzistilianou, M, Eboriadou, M, Athanasiadou-Piperopoulou, F. Hyponatraemia in cases of children with pneumonia. Arch Med Sci 2010;6:578–83. https://doi.org/10.5114/aoms.2010.14471.Search in Google Scholar PubMed PubMed Central

14. Lee, JY, Hwang, SJ, Shim, JW, Jung, HL, Park, MS, Woo, HY, et al.. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia. Korean J Lab Med 2010;30:406–13. https://doi.org/10.3343/kjlm.2010.30.4.406.Search in Google Scholar PubMed

15. Bray, C, Bell, LN, Liang, H, Haykal, R, Kaiksow, F, Mazza, JJ, et al.. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. Wis Med J 2016;115:317–21.Search in Google Scholar

16. de Jager, CP, Wever, PC, Gemen, EF, Kusters, R, van Gageldonk-Lafeber, AB, van der Poll, T, et al.. The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PloS One 2012;7:e46561. https://doi.org/10.1371/journal.pone.0046561.Search in Google Scholar PubMed PubMed Central

17. O’Brien, CE, Price, ET. The blood neutrophil to lymphocyte ratio correlates with clinical status in children with cystic fibrosis: a retrospective study. PloS One 2013;8:e77420. https://doi.org/10.1371/journal.pone.0077420.Search in Google Scholar PubMed PubMed Central

18. Uluca, U, Ece, A, Sen, V, Karabel, D, Yel, S, Gunes, A, et al.. Usefulness of mean platelet volume and neutrophil-to-lymphocyte ratio for evaluation of children with Familial Mediterranean fever. Med Sci Monit 2014;20:1578–82. https://doi.org/10.12659/MSM.892139.Search in Google Scholar PubMed PubMed Central

19. Kartal, O, Kartal, AT. Value of neutrophil to lymphocyte and platelet to lymphocyte ratios in pneumonia. Bratisl Lek Listy 2017;118:513–6. https://doi.org/10.4149/BLL_2017_099.Search in Google Scholar PubMed

20. Bekdas, M, Goksugur, SB, Sarac, EG, Erkocoglu, M, Demircioglu, F. Neutrophil/lymphocyte and C-reactive protein/mean platelet volume ratios in differentiating between viral and bacterial pneumonias and diagnosing early complications in children. Saudi Med J 2014;35:442–7.Search in Google Scholar

21. Gao, JB. Can mean platelet volume predict the prognosis of patients with community-acquired pneumonia? Am J Emerg Med 2015;33:727. https://doi.org/10.1016/j.ajem.2015.02.025.Search in Google Scholar PubMed

22. Golcuk, Y, Golcuk, B, Bilge, A, Irik, M, Dikmen, O. Combination of mean platelet volume and the CURB-65 score better predicts 28-day mortality in patients with community-acquired pneumonia. Am J Emerg Med 2015;33:648–52. https://doi.org/10.1016/j.ajem.2015.02.001.Search in Google Scholar PubMed

23. Ulubay, G, Ayvazoglu Soy, E, Serifoglu, I, Sozen, F, Moray, G, Haberal, M. Utility of mean platelet volume to diagnose pneumonia in patients with solid-organ transplant. Exp Clin Transplant 2018;16(1 Suppl):183–8. https://doi.org/10.6002/ect.TOND-TDTD2017.P58.Search in Google Scholar PubMed

24. Garcia Vazquez, E, Martinez, JA, Mensa, J, Sanchez, F, Marcos, MA, de Roux, A, et al.. C-reactive protein levels in community-acquired pneumonia. Eur Respir J 2003;21:702–5. https://doi.org/10.1183/09031936.03.00080203.Search in Google Scholar PubMed

25. Viasus, D, Garcia-Vidal, C, Simonetti, A, Manresa, F, Dorca, J, Gudiol, F, et al.. Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia. J Infect 2013;66:415–23. https://doi.org/10.1016/j.jinf.2012.12.007.Search in Google Scholar PubMed

26. Fairclough, E, Cairns, E, Hamilton, J, Kelly, C. Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. Clin Med 2009;9:30–3. https://doi.org/10.7861/clinmedicine.9-1-30.Search in Google Scholar PubMed PubMed Central

27. Seringec Akkececi, N, Yildirim Cetin, G, Gogebakan, H, Acipayam, C. The C-reactive protein/albumin ratio and complete blood count parameters as indicators of disease activity in patients with Takayasu Arteritis. Med Sci Monit 2019;25:1401–9. https://doi.org/10.12659/MSM.912495.Search in Google Scholar PubMed PubMed Central

28. Bozkurt, E, Muhafiz, E, Sengul, D, Ucak, T, Atum, M. Can the CRP/albumin ratio be used as a new indicator of activation in patients with uveitis? Ocul Immunol Inflamm 2020:1–6. https://doi.org/10.1080/09273948.2020.1714061.Search in Google Scholar PubMed

29. Zhou, T, Zhan, J, Hong, S, Hu, Z, Fang, W, Qin, T, et al.. Ratio of C-reactive protein/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer. Sci Rep 2015;5:10481. https://doi.org/10.1038/srep10481.Search in Google Scholar PubMed PubMed Central

30. Bozkurt, E, Ucak, T. Serum inflammation biomarkers in patients with keratoconus. Ocul Immunol Inflamm 2020:1–4. https://doi.org/10.1080/09273948.2020.1741648.Search in Google Scholar PubMed

31. Ventura, JC, Hauschild, DB, Moreira, EAM, Pereira, LCR, Rosa, AF, Barbosa, E, et al.. C-reactive protein/albumin ratio is associated with lung function among children/adolescents with cystic fibrosis: a three-year longitudinal study. Sao Paulo Med J 2018;136:29–36. https://doi.org/10.1590/1516-3180.2017.0109100917.Search in Google Scholar PubMed

32. Lee, JH, Kim, J, Kim, K, Jo, YH, Rhee, J, Kim, TY, et al.. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia. J Crit Care 2011;26:287–94. https://doi.org/10.1016/j.jcrc.2010.10.007.Search in Google Scholar PubMed

33. Sanz, F, Fernandez Fabrellas, E, Chiner, E, Briones, ML, Cervera, A, Aguar, C, et al.. Inflammatory-based prognostic score, C-reactive protein/albumin ratio predicts complications in community-acquired pneumonia. In: C61. Pulmonary infections: clinical investigations. American Thoracic Society; 2018:5499 p.Search in Google Scholar

34. Reinhart, WH, Nagy, C. Albumin affects erythrocyte aggregation and sedimentation. Eur J Clin Invest 1995;25:523–8. https://doi.org/10.1111/j.1365-2362.1995.tb01739.x.Search in Google Scholar PubMed

Received: 2020-05-09
Accepted: 2021-03-24
Published Online: 2021-05-11

© 2021 Hayrunnisa Bekis Bozkurt, published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 2.5.2024 from https://www.degruyter.com/document/doi/10.1515/tjb-2020-0228/html
Scroll to top button